Adjuvant trastuzumab without chemotherapy for treating early HER2-positive breast cancer in older patients: A propensity score-adjusted analysis of a prospective cohort study

PURPOSE: To gauge the effects of treatment practices on prognosis for older patients with HER2-positive early breast cancer, particularly to determine whether adjuvant trastuzumab alone can offer benefit over no adjuvant therapy. This is a prospective cohort study which accompanies the RESPECT that...

Descripción completa

Detalles Bibliográficos
Autores principales: Sawaki, Masataka, Taira, Naruto, Uemura, Yukari, Saito, Tsuyoshi, Baba, Shinichi, Kobayashi, Kokoro, Kawashima, Hiroaki, Tsuneizumi, Michiko, Sagawa, Noriko, Bando, Hiroko, Takahashi, Masato, Yamaguchi, Miki, Takashima, Tsutomu, Nakayama, Takahiro, Kashiwaba, Masahiro, Mizuno, Toshiro, Yamamoto, Yutaka, Iwata, Hiroji, Toyama, Tatsuya, Tsugawa, Koichiro, Kawahara, Takuya, Mukai, Hirofumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661716/
https://www.ncbi.nlm.nih.gov/pubmed/36371994
http://dx.doi.org/10.1016/j.breast.2022.10.017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661716/
https://www.ncbi.nlm.nih.gov/pubmed/36371994
http://dx.doi.org/10.1016/j.breast.2022.10.017

Ejemplares similares